Physician

Jonathan Samuel Fuerst, M.D.

According to 2025 Medicare claims, Jonathan Fuerst, M.D. (NPI: 1811421555) practices ophthalmology in the Knoxville, TN market, with the plurality of this provider's patient population coming from Knox, TN. This provider's primary affiliated billing organization is SOUTHEASTERN RETINA ASSOCIATES, P.C. (NPI: 1932200664; TIN: 621094813) and primary practice location at 37922-3572.

Fuerst's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 922 traditional Medicare patients, billed 28,979 HCPCS/CPT codes, and received $2,090,330 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 682 prescription claims across 232 beneficiaries totaling $19,564 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 33 records totaling $1,053. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,621 and ending at $19,564. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.0M$2.1M2021 Medicare payment: $14,327 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $108,738 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $802,446 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,090,330 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021102164$14,327
2022328846$108,738
20236307,081$802,446
202492228,979$2,090,330

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$9.8K$20K2017 Drug cost: $4,621 (USD; Tot_Drug_Cst)2018 Drug cost: $3,399 (USD; Tot_Drug_Cst)2019 Drug cost: $10,025 (USD; Tot_Drug_Cst)2020 Drug cost: $3,084 (USD; Tot_Drug_Cst)2021 Drug cost: $8,584 (USD; Tot_Drug_Cst)2022 Drug cost: $5,326 (USD; Tot_Drug_Cst)2023 Drug cost: $9,371 (USD; Tot_Drug_Cst)2024 Drug cost: $19,564 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20172064$4,621
20184098$3,399
201963148$10,025
20203494$3,084
202175225$8,584
202273125$5,326
2023133257$9,371
2024232682$19,564

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system175175$102
67028Injection of drug into eye2241,139$91
92014Established patient complete exam of visual system546647$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more305396$66
92134Imaging of retina8882,324$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1956,923$9,464
Ketorolac TromethamineKetorolac Tromethamine1034,569$2,251
Brimonidine TartrateBrimonidine Tartrate351,985$1,495
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha1122,275$1,394
Atropine SulfateAtropine Sulfate361,689$1,355

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.33$1,053Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jonathan Samuel Fuerst, M.D.?

Tedicare shows public-source Medicare data for Jonathan Samuel Fuerst, M.D. (NPI 1811421555), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jonathan Samuel Fuerst, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jonathan Samuel Fuerst, M.D.?

Jonathan Samuel Fuerst, M.D. is linked to SOUTHEASTERN RETINA ASSOCIATES, P.C. (billing NPI 1932200664) in the available physician profile data.

Does Jonathan Samuel Fuerst, M.D. have Open Payments data?

Jonathan Samuel Fuerst, M.D. has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.